BALAJI AMINES LTD.-$ - 530999 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Submission of Q4FY24 Earnings Call Transcript under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201516-05-2024
16-05-2024
BALAJI AMINES LTD.-$ - 530999 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Audio Recording of Conference Call held on 10th May, 2024 to discuss Q4FY24 Financial Results.10-05-2024
BALAJI AMINES LTD.-$ - 530999 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation on Q4FY2024 Financial Results10-05-2024
BALAJI AMINES LTD.-$ - 530999 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Newspaper Advertisements of Extract of Standalone and Consolidated Financial Results of the Company for the Quarter and Year ended 31st March, 2024, published in Business Standard (English) and Lokmat (Marathi).09-05-2024
Q4FY24 Quarterly Result Announced for Balaji Amines Ltd.
Speciality Chemicals company Balaji Amines announced Q4FY24 results: Financial Highlights: Revenue from Operations for Q4FY24 stood at Rs 423 crore, as compared to Rs 392 crore in Q3FY24. Total volumes stood at 27,984 MT for Q4FY24 as against 26,903 MT in Q3FY24. For Q4FY24, Amines volumes stood at 8,910 MT Amines Derivatives volumes stood at 9,676 MT Specialty Chemicals volumes stood at 9,398 MT EBITDA for Q4FY24 was Rs 106 crore, as compared to Rs 83 crore in Q3FY24. EBITDA margin for Q4FY24 stood at 25% as against 21% in Q3FY24. PAT for Q4FY24 was Rs 72 crore as compared to Rs 56 crore in Q3FY24. Diluted EPS for Q4FY24 stood at Rs 21.00 per equity share as against Rs 15.24 in Q3FY24. On a standalone basis, it is a zero-debt company. On the performance, D. Ram Reddy, Managing Director, commented, “In Q4 & FY24, our financial and business highlights indicate a positive trajectory, with higher volume uptake, improved EBITDA and PAT margins driven by stabilised input costs(on both raw materials and utilities fronts) and a settling industry scenario. The rebound in domestic demand, coupled with encouraging international market trends, is contributing to this momentum and enhancing our margins. Recent developments include the successful commencement of n-Butylamines production at Unit-IV, boasting an annual installed capacity of 15,000 MT. Furthermore, Unit-I and Unit-III have received BIS Certification for 'Morpholine,' enhancing our product quality standards. Both Methylamine and Dimethyl Ether projects are progressing well, showcasing our commitment to operational excellence. Looking ahead, we maintain a positive outlook for long-term opportunities, anticipating growth and increased prospects in the fiscal year 2024- 25. Our focus on inherent strengths and competencies positions us as a leading force in Amines and Specialty Chemicals, guiding us through market complexities towards greater excellence.” Result PDF09-05-2024
BALAJI AMINES LTD.-$ - 530999 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release in connection with the Audited Financial Results for the Quarter and Year ended 31st March, 2024.08-05-2024
Balaji Amines Announces Final Dividend Of Rs 11 Per Share
The dividend will be paid after approval from shareholders at the ensuing annual general meeting.08-05-2024
BALAJI AMINES LTD.-$ - 530999 - Corporate Action-Board approves Dividend
The Board of Directors have recommended a final dividend of Rs. 11/- per Equity Share on face value of Rs. 2/- each (i.e. 550%) for the financial year 2023-24. The same will be payable after it is approved by the shareholders in the ensuing Annual General Meeting of the Company.08-05-2024
BALAJI AMINES LTD.-$ - 530999 - Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting08-05-2024
BALAJI AMINES LTD.-$ - 530999 - Results- Financial Results 31St March, 2024
Outcome of Board Meeting08-05-2024